RE:Interview about positive interim results from Phase II BCS Thanks for the link, an amazing interview! This is much more than just promising, as it proves the science behind TLT's is a winner. Roger stated that they will wait until the completion of the phase 2 trial (100 patients) prior to submitting to the FDA for commercial approval (possible mid 2024 ?). This puts us at least a year away from an appreciable increase in stare price, not sure if BTD is still on the table after watching this interview. If it is, BTD will create a small pop in share price, but nowhere near where most longs would be willing to sell at. For that payday we will be patiently waiting at least another year by the looks of it. I'm okay to wait